SCHEMBL10593297

SCHEMBL10593297

CC1=CC2=C(CC1=O)Sc1cc(C)ccc1N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.47
▸ MAPT P10636 7/20 0.40
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ ALOX15 P16050 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ GAA P10253 3/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ NOX1 Q9Y5S8 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ ALDH1A1 P00352 6/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ POLB P06746 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1201818 0.84 L3MBTL1 (0.45) MAPTMEN1KMT2AALOX15HSD17B10
SCHEMBL10591877 0.79 EPHX2 (0.48) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL10590860 0.75 EPHX2 (0.47) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL9813228 0.71 SNCA (0.52) MAPTMEN1KMT2AALOX15HSD17B10
SCHEMBL10591899 0.71 NOX1 (0.43) MAPTMEN1KMT2AALOX15HSD17B10
SCHEMBL11287177 0.70 KDM4E (0.31) MAPTMEN1KMT2AGAANOX1
SCHEMBL10591953 0.70 EPHX2 (0.41) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL29640485 0.69 MAPT (0.59) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL225916 0.69 MAPT (0.59) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL10592010 0.69 NOX1 (0.39) MAPTMEN1KMT2AALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0115394-B1 PHENOTHIAZONE DERIVATIVES AND ANALOGS MERCK FROSST CANADA INC. (CA) 1989-06-28 — — EP disclosed
EP-0155623-A2 Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition MERCK & CO. INC. (US) 1985-09-25 — — EP disclosed
EP-0115394-A2 Phenothiazone derivatives and analogs MERCK FROSST CANADA INC. (CA) 1984-08-08 — — EP disclosed
Send feedback